Publications by authors named "Christina E Wong"

Article Synopsis
  • - The MET receptor is crucial for various biological processes, but its dysregulation is linked to cancers like non-small cell lung cancer and renal cancer, highlighting a significant medical need for better treatment options.
  • - Current MET inhibitors face challenges such as resistance and toxicity, particularly in treating brain metastases, which further emphasizes the demand for improved therapies.
  • - Researchers are developing a new class of MET inhibitors designed to effectively target brain tumors and specific cancer mutations, which showed promising results in preclinical models, significantly extending survival in treated animals.
View Article and Find Full Text PDF

SHP2 has emerged as an important target for oncology small-molecule drug discovery. As a nonreceptor tyrosine phosphatase within the MAPK pathway, it has been shown to control cell growth, differentiation, and oncogenic transformation. We used structure-based design to find a novel class of potent and orally bioavailable SHP2 inhibitors.

View Article and Find Full Text PDF

Unlabelled: Rationally targeted therapies have transformed cancer treatment, but many patients develop resistance through bypass signaling pathway activation. PF-07284892 (ARRY-558) is an allosteric SHP2 inhibitor designed to overcome bypass-signaling-mediated resistance when combined with inhibitors of various oncogenic drivers. Activity in this setting was confirmed in diverse tumor models.

View Article and Find Full Text PDF

From a high throughput screening of commercially available libraries against nontuberculous mycobacteria and Mycobacterium tuberculosis, numerous hits were identified with moderate activity. Extensive medicinal chemistry optimization has led to a series of potent benzothiazole amide antimycobacterial agents. Replacement of the adamantyl group with cyclohexyl derivatives and further development of this series resulted in an advanced lead compound, CRS400393, which demonstrated excellent potency and a mycobacteria-specific spectrum of activity.

View Article and Find Full Text PDF

A convenient copper-catalyzed intramolecular/intermolecular alkene diamination reaction to synthesize 3-aminomethyl-functionalized isoxazolidines under mild reaction conditions and with generally high levels of diastereoselectivity was achieved. This reaction demonstrates that previously underutilized unsaturated carbamates are good [Cu]-catalyzed diamination substrates. Sulfonamides, anilines, benzamide, morpholine, and piperidine can serve as the external amine source.

View Article and Find Full Text PDF